TEST:

Uromonitor®

Uromonitor® is a CE-certified novel urine-based test with 100% Sensitivity, independently of tumor stage and grade, and 97.3% Specificity biomarker for Non-Muscle invasive bladder cancer. It can be used for detecting the tumor in patients under recurrence surveillance or suspected of bladder cancer (e.g. hematuria), ancillary to cystoscopy and urine cytology. It has been validated in multicenter studies and exhibits high sensitivity and specificity.